Tuesday, June 19, 2018 11:07:34 AM
Arrayit CLIA clinical team confirms 7/2/2018 meeting with top officials at the United States Food and Drug Administration FDA headquartered in Silver Spring Maryland USA to discuss FDA regulatory clearance of a major microarray technology product line fda.gov
Arrayit has developed an advanced blood card technology that collects and fractionates whole blood into red blood cells, white blood cells and serum components quickly, easily and affordably. Our unique linear separation chromatography process collects 5 droplets of whole blood and separates and dries the whole blood components in 10 minutes. Arrayit Blood Cards can be used to fractionate, ship, sample and store samples for a variety of applications in research, veterinary medicine and pathology including protein-based allergy testing and cancer research. Arrayit Blood Cards can also be used to isolate DNA and mRNA samples for genotyping and expression profiling applications. Private labeling is available for large OEM accounts.
http://www.arrayit.com/Microarray_Diagnostics/Blood_Cards/blood_cards.html
July 2 is just 2 weeks away
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM